CS-Divipet

**CS-Divipet** is a DreemBio veterinary phytotherapeutic product described as a standardized polymolecular extract of *Caesalpinia spinosa* (dividivi). DreemBio and Colombia's Portafolio BIO describe it as a product for veterinary cancer control in small and large mammals, with claimed reduction of primary tumors and metastases through activation of antitumor immune responses. Its specific bioactive constituents, molecular targets, dosage form, route of administration, regulatory approval status, and controlled clinical-study evidence were not identified in the reviewed public sources. ([portafoliobio.minciencias.gov.co](https://portafoliobio.minciencias.gov.co/?project=cs-divipet))